Phase I/IIa study of Allogenic Osteoblastic Cells (ALLOB) for the revision of failed Spinal fusion.
Phase of Trial: Phase I/II
Latest Information Update: 21 Oct 2016
At a glance
- Drugs Allogeneic osteoblastic cell therapy Bone Therapeutics (Primary)
- Indications Intervertebral disc degeneration
- Focus Therapeutic Use
- 21 Oct 2016 New trial record